Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVRX CVRx	$5.03 +2.9%	$6.75	$4.37 ▼ $11.30	$129.76M	0.8	316,972 shs	264,367 shs
KIDS OrthoPediatrics	$17.82 -0.1%	$17.12	$14.42 ▼ $23.70	$457.96M	1.03	116,609 shs	96,185 shs
MDXG MiMedx Group	$3.60 -2.4%	$3.63	$3.03 ▼ $7.99	$549.61M	1.48	1.26 million shs	947,120 shs
NPCE NeuroPace	$15.64 -1.3%	$16.12	$7.56 ▼ $19.60	$540.04M	1.88	136,644 shs	83,997 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVRX CVRx	+2.17%	-15.87%	-6.36%	-34.46%	-25.34%
KIDS OrthoPediatrics	-3.41%	-1.49%	+0.62%	+3.00%	-19.32%
MDXG MiMedx Group	+1.37%	-2.38%	+4.24%	-15.75%	-42.52%
NPCE NeuroPace	+0.83%	-2.94%	+0.25%	+12.42%	+33.90%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVRX CVRx	$5.03 +2.9%	$6.75	$4.37 ▼ $11.30	$129.76M	0.8	316,972 shs	264,367 shs
KIDS OrthoPediatrics	$17.82 -0.1%	$17.12	$14.42 ▼ $23.70	$457.96M	1.03	116,609 shs	96,185 shs
MDXG MiMedx Group	$3.60 -2.4%	$3.63	$3.03 ▼ $7.99	$549.61M	1.48	1.26 million shs	947,120 shs
NPCE NeuroPace	$15.64 -1.3%	$16.12	$7.56 ▼ $19.60	$540.04M	1.88	136,644 shs	83,997 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVRX CVRx	+2.17%	-15.87%	-6.36%	-34.46%	-25.34%
KIDS OrthoPediatrics	-3.41%	-1.49%	+0.62%	+3.00%	-19.32%
MDXG MiMedx Group	+1.37%	-2.38%	+4.24%	-15.75%	-42.52%
NPCE NeuroPace	+0.83%	-2.94%	+0.25%	+12.42%	+33.90%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVRX CVRx	3.00	Buy	$11.50	128.63% Upside
KIDS OrthoPediatrics	2.82	Moderate Buy	$24.44	37.17% Upside
MDXG MiMedx Group	2.71	Moderate Buy	$8.50	136.11% Upside
NPCE NeuroPace	2.88	Moderate Buy	$18.83	20.42% Upside

Current Analyst Ratings Breakdown

Latest CVRX, MDXG, NPCE, and KIDS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/18/2026	MDXG MiMedx Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
5/15/2026	NPCE NeuroPace	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$19.00 ➝ $20.00
5/6/2026	CVRX CVRx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
5/4/2026	MDXG MiMedx Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
5/1/2026	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$17.00
5/1/2026	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$24.00
4/30/2026	MDXG MiMedx Group	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Market Outperform	$7.00 ➝ $6.00
4/24/2026	KIDS OrthoPediatrics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00
4/21/2026	KIDS OrthoPediatrics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
4/20/2026	MDXG MiMedx Group	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform	$10.00 ➝ $7.00
4/17/2026	MDXG MiMedx Group	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$10.00 ➝ $7.00

(Data available from 6/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVRX CVRx	$56.65M	2.36	N/A	N/A	$1.50 per share	3.35
KIDS OrthoPediatrics	$236.35M	1.94	$0.17 per share	107.22	$13.82 per share	1.29
MDXG MiMedx Group	$418.63M	1.28	$0.54 per share	6.66	$1.73 per share	2.08
NPCE NeuroPace	$99.99M	5.33	N/A	N/A	$0.57 per share	27.44

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVRX CVRx	-$53.31M	-$2.02	N/A	N/A	N/A	-89.14%	-120.76%	-48.38%	8/4/2026 (Estimated)
KIDS OrthoPediatrics	-$39.65M	-$1.68	N/A	N/A	N/A	-16.31%	-7.01%	-4.86%	8/4/2026 (Estimated)
MDXG MiMedx Group	$48.58M	$0.20	10.85	60.00	N/A	7.88%	21.03%	15.92%	7/29/2026 (Estimated)
NPCE NeuroPace	-$21.47M	-$0.65	N/A	N/A	N/A	-21.67%	-108.20%	-18.50%	8/11/2026 (Estimated)

Latest CVRX, MDXG, NPCE, and KIDS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/12/2026	Q1 2026	NPCE NeuroPace	-$0.19	-$0.13	+$0.06	-$0.20	$21.65 million	$22.00 million
5/11/2026	Q1 2026	CVRX CVRx	-$0.51	-$0.50	+$0.01	-$0.50	$14.49 million	$14.77 million
4/30/2026	Q1 2026	KIDS OrthoPediatrics	-$0.4552	-$0.42	+$0.0352	-$0.45	$58.29 million	$59.36 million
4/29/2026	Q1 2026	MDXG MiMedx Group	-$0.07	-$0.05	+$0.02	-$0.07	$65.80 million	$58.99 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVRX CVRx	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
MDXG MiMedx Group	N/A	N/A	N/A	N/A	N/A
NPCE NeuroPace	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVRX CVRx	2.01	10.20	8.89
KIDS OrthoPediatrics	0.29	5.21	2.37
MDXG MiMedx Group	0.07	5.39	4.81
NPCE NeuroPace	4.08	5.38	4.35

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVRX CVRx	75.27%
KIDS OrthoPediatrics	69.05%
MDXG MiMedx Group	79.15%
NPCE NeuroPace	78.83%

Insider Ownership

Company	Insider Ownership
CVRX CVRx	13.90%
KIDS OrthoPediatrics	32.70%
MDXG MiMedx Group	2.50%
NPCE NeuroPace	20.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVRX CVRx	160	26.54 million	22.85 million	Optionable
KIDS OrthoPediatrics	200	25.68 million	17.29 million	Optionable
MDXG MiMedx Group	870	148.95 million	145.22 million	Optionable
NPCE NeuroPace	170	34.09 million	27.11 million	Optionable

CVRX, MDXG, NPCE, and KIDS Headlines

Recent News About These Companies

NeuroPace Stock Draws Focus As RNS Adoption Expands

June 11 at 5:04 PM | kalkinemedia.comK

NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound?

June 11 at 12:32 PM | zacks.com

Here's Why You Should Add NeuroPace Stock to Your Portfolio Now

June 10 at 11:41 AM | zacks.com

NeuroPace Shareholders Approve Directors and Auditor at Meeting

June 8, 2026 | tipranks.com

Solana (NASDAQ:HSDT) and NeuroPace (NASDAQ:NPCE) Head to Head Contrast

June 3, 2026 | americanbankingnews.com

How The NeuroPace (NPCE) Investment Story Is Shifting Without A New Analyst Price Target

June 2, 2026 | finance.yahoo.com

NPCE Receives FDA Approval for AI-Powered ECoG Assistant for Epilepsy

June 2, 2026 | zacks.com

NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting

May 29, 2026 | businesswire.com

NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care

May 29, 2026 | businesswire.com

Analysts Conflicted on These Healthcare Names: NeoGenomics (NEO) and NeuroPace (NPCE)

May 28, 2026 | theglobeandmail.com

Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?

May 27, 2026 | zacks.com

NPCE Explains How NeuroPace's RNS System Makes Money

May 27, 2026 | zacks.com

NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care

May 27, 2026 | zacks.com

NeuroPace (NPCE) Q1 2026 Earnings Transcript

May 15, 2026 | finance.yahoo.com

NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 15, 2026 | finance.yahoo.com

Neuropace signals $99M-$101M 2026 revenue outlook while targeting 21%-23% underlying RNS growth

May 14, 2026 | seekingalpha.com

NPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised

May 13, 2026 | zacks.com

NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript

May 12, 2026 | seekingalpha.com

NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates

May 12, 2026 | zacks.com

NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance

May 12, 2026 | businesswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVRX, MDXG, NPCE, and KIDS Company Descriptions

CVRx NASDAQ:CVRX

$5.03 +0.14 (+2.86%)

Closing price 04:00 PM Eastern

Extended Trading

$5.08 +0.05 (+0.99%)

As of 06:25 PM Eastern

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

OrthoPediatrics NASDAQ:KIDS

$17.82 -0.01 (-0.06%)

Closing price 04:00 PM Eastern

Extended Trading

$17.84 +0.02 (+0.11%)

As of 05:35 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

MiMedx Group NASDAQ:MDXG

$3.60 -0.09 (-2.44%)

Closing price 04:00 PM Eastern

Extended Trading

$3.60 0.00 (0.00%)

As of 04:10 PM Eastern

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

NeuroPace NASDAQ:NPCE

$15.64 -0.20 (-1.26%)

Closing price 04:00 PM Eastern

Extended Trading

$15.64 +0.00 (+0.03%)

As of 06:27 PM Eastern

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CVRX, MDXG, NPCE, and KIDS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CVRX, MDXG, NPCE, and KIDS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CVRX, MDXG, NPCE, and KIDS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVRX, MDXG, NPCE, and KIDS Company Descriptions

CVRx NASDAQ:CVRX

OrthoPediatrics NASDAQ:KIDS

MiMedx Group NASDAQ:MDXG

NeuroPace NASDAQ:NPCE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CVRX, MDXG, NPCE, and KIDS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CVRX, MDXG, NPCE, and KIDS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CVRX, MDXG, NPCE, and KIDS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVRX, MDXG, NPCE, and KIDS Company Descriptions

CVRx NASDAQ:CVRX

OrthoPediatrics NASDAQ:KIDS

MiMedx Group NASDAQ:MDXG

NeuroPace NASDAQ:NPCE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools